Share
3,387 Posts.
lightbulb Created with Sketch. 4561
clock Created with Sketch.
13/07/20
13:41
Share
Originally posted by Bomber78:
↑
Breaking into $280B industry.
Discussions continue with leading nutraceutical and pharmaceutical distributors globally, with the aim of entering into Purchase Agreements to further build on the strong foundations of established revenue streams.
European Union Listing Approval received for export of marine products to Europe.
US Food and Drug Administration Listing Approval received to export products to the United States in May.
NZ$4.4m purchase agreement with SuperMilkBaba (NZ) Limited, for the sale of a minimum of 100 tonnes of frozen ling maw over a 12 month period, with the first 1000kg shipment dispatched in March 2020, on advance payment terms.
Ling Maw sells for $1/gram!
Daigou traction.
Signed a distribution agreement with Chinese distributor who has big brand names such as Colgate in their portfolio.
Just upgraded their production warehouse by 6 x the space of the previous one.
Big sleeper.
Could well be cash flow positive very soon.
***Disallowed potential***
Expand
I'm in with an initial parcel at 0.9c. I like the direction the company is moving in. Minimal downside from these levels. Even on zero growth, NZS should trade on 2x revenue. Moreover, the business is continuing to de-risk itself. I will provide more thoughts over the coming days.